ANGELA JOHNSON: Open Payments
NPI 1811144264 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,985 in 104 payments from 14 companies in 2025. Trend: 2023 $1,364 · 2024 $1,336 · 2025 $1,985
Food & beverage: $1,985
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $297 |
| ABBVIE INC. | 18 | $264 |
| Teva Pharmaceuticals USA, Inc. | 11 | $218 |
| Neurocrine BioSciences, Inc. | 10 | $216 |
| Otsuka America Pharmaceutical, Inc. | 8 | $183 |
| Vanda Pharmaceuticals Inc. | 8 | $168 |
| Alkermes, Inc. | 11 | $163 |
| Axsome Therapeutics, Inc. | 7 | $156 |
| Lundbeck LLC | 5 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
Products named: COBENFY, REXULTI, VRAYLAR, INGREZZA, ARISTADA, Auvelity, AUSTEDO XR, HETLIOZ.
Industry payments across OH — which companies pay providers there.
